tiprankstipranks
Trending News
More News >
GMO Pepabo, Inc. (JP:3633)
:3633
Japanese Market

GMO Pepabo, Inc. (3633) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3633

GMO Pepabo, Inc.

(3633)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 5.2)
Rating:65Neutral
Price Target:
¥2,192.00
▼(-1.79% Downside)
Action:DowngradedDate:02/18/26
The score is led by improved financial fundamentals (margin recovery, better leverage, and solid 2025 free cash flow) and supportive valuation (low P/E with a ~3.29% yield). These positives are offset by weak technicals (below key moving averages and negative MACD) and limited revenue growth, which reduce confidence in near-term momentum.
Positive Factors
Margin recovery and resilient unit economics
Recovering net and operating margins alongside steady gross margins (53–58%) indicate durable unit economics. This suggests the company can sustain profitability through cost control and pricing power in its hosting/domain business, supporting long-term earnings stability if revenue steadies.
Improved leverage and balance sheet
A materially lower debt-to-equity (0.31 vs 0.82) reduces financial risk and interest burden, increasing strategic flexibility for reinvestment or shareholder returns. A stronger balance sheet improves resilience to shocks and supports sustained operating plans over the medium term.
Solid free cash flow generation
Robust FCF that approximates net income demonstrates earnings quality and internal funding capacity. Reliable cash generation supports capex, platform improvements, and optional shareholder returns, reducing reliance on external financing for durable business operations.
Negative Factors
Stagnant to slightly down revenue
Limited top-line growth constrains scalability: without sustained revenue expansion, margin gains must come from cost cuts, limiting long-term upside. For platform businesses, growth is essential to leverage fixed costs and expand market share among SMB and creator customers.
Historical cash-flow volatility
Material swings in operating and free cash flow reduce predictability for capex, dividends, and debt service. Volatility signals sensitivity to working-capital and timing effects, raising execution risk and necessitating consistent earnings to lock in recent balance-sheet improvements.
Volatile historical leverage
Prior episodes of much higher debt show leverage can worsen if cash flow or earnings deteriorate. This history elevates refinancing and interest-rate risk if growth stalls, meaning management must sustain profits to prevent balance-sheet deterioration over the medium term.

GMO Pepabo, Inc. (3633) vs. iShares MSCI Japan ETF (EWJ)

GMO Pepabo, Inc. Business Overview & Revenue Model

Company DescriptionGMO Pepabo, Inc. provides consumer-targeted Internet services in Japan. It operates through four segments: Hosting, Ecommerce Support, Customer to Customer (C2C), and Community. The Hosting segment offers consumer domain registration and web hosting services. The Ecommerce Support segment provides ecommerce platform solutions. The C2C segment offers marketplace for handmade products. The Community segment facilitates communication among Internet users through blogging. The company was formerly known as Paperboy&Co., Inc. and changed its name to GMO Pepabo, Inc. in March 2014. The company was founded in 2003 and is headquartered in Tokyo, Japan. GMO Pepabo, Inc operates as a subsidiary of GMO Internet, Inc
How the Company Makes MoneyGMO Pepabo generates revenue primarily through its diverse range of internet-related services. Key revenue streams include subscription fees from web hosting and domain registration services, which cater to both individual users and businesses. The company also earns income from e-commerce solutions, offering platforms that allow users to create online stores. Additionally, GMO Pepabo benefits from partnerships with various technology providers and has a strong presence in the Japanese market, which enhances its customer base and drives consistent revenue growth. Special promotions, value-added services, and customer retention strategies further contribute to its earnings.

GMO Pepabo, Inc. Financial Statement Overview

Summary
Profitability has rebounded strongly after 2023, with net margin ~8.0% and operating margin ~8.5% in 2025, while gross margin stayed healthy (~53–58%). Leverage improved meaningfully (debt-to-equity ~0.31 in 2025 vs. ~0.82 in 2023) and 2025 cash generation was solid (FCF ~¥1.37B, ~0.94x net income). The main constraint is flat-to-slightly down revenue and historical cash-flow volatility (notably 2022).
Income Statement
68
Positive
Profitability recovered meaningfully after a loss in 2023, with net margin improving to ~8.0% in 2025 (vs. ~5.4% in 2024 and negative in 2023) and operating margin back to ~8.5%. Gross margin has been steady and healthy (~53–58%) across the period, indicating resilient unit economics. The key weakness is growth: revenue has been essentially flat for several years and slightly down in 2025, suggesting limited top-line momentum despite better cost control.
Balance Sheet
70
Positive
Leverage looks manageable and has improved: debt-to-equity declined to ~0.31 in 2025 from ~0.82 in 2023, alongside a rising equity base. Total assets have been relatively stable, and the balance sheet appears less stretched than during the 2023 downturn. The main risk is that leverage has been volatile historically (including materially higher debt levels in 2022–2023), so continued earnings consistency matters to keep the improving trend intact.
Cash Flow
73
Positive
Cash generation is a clear strength recently: operating cash flow and free cash flow were solid in 2025 (~¥1.46B and ~¥1.37B), with free cash flow roughly matching net income (about 0.94x), supporting earnings quality. The weakness is variability: 2022 showed negative operating cash flow and free cash flow, and free cash flow has swung materially year to year, indicating working-capital and/or investment timing can create volatility.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue11.10B10.96B10.92B10.90B10.53B11.88B
Gross Profit6.00B5.96B5.78B5.93B6.08B6.73B
EBITDA1.53B1.44B1.47B84.16M1.12B1.36B
Net Income663.90M878.44M591.63M-628.79M510.09M715.41M
Balance Sheet
Total Assets10.98B11.32B11.42B10.87B11.44B8.87B
Cash, Cash Equivalents and Short-Term Investments5.04B5.75B4.92B4.36B3.61B3.62B
Total Debt600.00M857.45M1.19B1.48B1.57B209.15M
Total Liabilities8.61B8.52B9.03B9.06B8.75B5.92B
Stockholders Equity2.37B2.80B2.39B1.81B2.69B2.93B
Cash Flow
Free Cash Flow0.001.37B901.23M1.38B-708.88M338.84M
Operating Cash Flow0.001.46B1.21B1.78B-213.40M669.08M
Investing Cash Flow0.00236.62M-292.00M-325.63M-510.15M-278.35M
Financing Cash Flow0.00-859.23M-361.39M-702.63M712.28M-392.52M

GMO Pepabo, Inc. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2232.00
Price Trends
50DMA
2158.64
Negative
100DMA
2106.38
Negative
200DMA
1840.45
Positive
Market Momentum
MACD
-32.31
Negative
RSI
42.71
Neutral
STOCH
18.21
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3633, the sentiment is Neutral. The current price of 2232 is above the 20-day moving average (MA) of 2056.35, above the 50-day MA of 2158.64, and above the 200-day MA of 1840.45, indicating a neutral trend. The MACD of -32.31 indicates Negative momentum. The RSI at 42.71 is Neutral, neither overbought nor oversold. The STOCH value of 18.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3633.

GMO Pepabo, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥49.71B28.220.52%26.98%19.69%
65
Neutral
¥10.84B12.152.16%2.75%25.24%
64
Neutral
¥613.64B27.3819.76%1.47%11.81%16.69%
61
Neutral
¥17.95B90.382.31%9.71%-70.49%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
61
Neutral
¥16.36B-46.59
52
Neutral
¥120.74B162.310.14%36.42%28.23%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3633
GMO Pepabo, Inc.
2,049.00
701.76
52.09%
JP:3769
GMO Payment Gateway
8,091.00
741.20
10.08%
JP:3665
ENIGMO, Inc.
431.00
139.24
47.72%
JP:3778
SAKURA Internet Inc.
3,020.00
-980.91
-24.52%
JP:4431
Smaregi, Inc.
2,541.00
86.61
3.53%
JP:4434
Serverworks Co., Ltd.
2,062.00
-280.89
-11.99%

GMO Pepabo, Inc. Corporate Events

GMO Pepabo Boosts Profit and Dividend on Stable 2025 Sales
Feb 10, 2026

GMO Pepabo reported flat net sales of ¥10.96 billion for the year ended 31 December 2025, but sharply higher profitability, with operating profit up 12.5% to ¥932 million and profit attributable to owners of parent surging 48.5% to ¥878 million. The company strengthened its financial base, lifting its equity ratio to 24.7%, growing year-end cash and cash equivalents to ¥5.75 billion, and more than doubling the annual dividend to ¥111 per share, including a special payout.

The group also recorded higher net assets, reflecting improved earnings and capital efficiency, while reshaping its consolidation scope by adding CN Inc. and excluding GMO Creators Network, Inc. For 2026, Pepabo forecasts modest sales growth to ¥11.0 billion and a further rise in operating profit to ¥1.05 billion, but projects lower ordinary profit and net income as profitability normalizes after the strong 2025 results.

The most recent analyst rating on (JP:3633) stock is a Buy with a Yen2442.00 price target. To see the full list of analyst forecasts on GMO Pepabo, Inc. stock, see the JP:3633 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026